FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: A phase II study of safety, tolerability, and anti-inflammatory activity

Lehrer Graiwer Joshua, Parmanand Singh, Amr Abdelbaky, Esad Vucic, Magnus Korsgren, Amos Baruch, Jill Fredrickson, Nick Van Bruggen, Meina T. Tang, Bjorn Frendeus, James H.F. Rudd, Frank Hsieh, Christie M. Ballantyne, Brian Ghoshhajra, Robert S. Rosenson, Michael Koren, Eli M. Roth, Daniel A. Duprez, Zahi A. Fayad, Ahmed A. Tawakol

Research output: Contribution to journalLetter

33 Scopus citations
Original languageEnglish (US)
Pages (from-to)493-494
Number of pages2
JournalJACC: Cardiovascular Imaging
Volume8
Issue number4
DOIs
StatePublished - Apr 1 2015

Cite this

Joshua, L. G., Singh, P., Abdelbaky, A., Vucic, E., Korsgren, M., Baruch, A., Fredrickson, J., Van Bruggen, N., Tang, M. T., Frendeus, B., Rudd, J. H. F., Hsieh, F., Ballantyne, C. M., Ghoshhajra, B., Rosenson, R. S., Koren, M., Roth, E. M., Duprez, D. A., Fayad, Z. A., & Tawakol, A. A. (2015). FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: A phase II study of safety, tolerability, and anti-inflammatory activity. JACC: Cardiovascular Imaging, 8(4), 493-494. https://doi.org/10.1016/j.jcmg.2014.06.021